Post-Birth sugar check reveals hidden diabetes risk in moms

NCT ID NCT01839448

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 500 women who had gestational diabetes during pregnancy. They took a glucose test 4 to 12 weeks after giving birth to see how many had type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose. The goal was to compare women diagnosed with gestational diabetes before 24 weeks of pregnancy versus those diagnosed after 24 weeks. The study does not test a treatment but aims to improve understanding of postpartum diabetes risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand when to screen for diabetes after pregnancy, leading to earlier detection and prevention of type 2 diabetes.
What could go wrong: This is an observational study, not a treatment trial. It only measures outcomes without testing any intervention, so it cannot directly improve health. Results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gestational diabetes glucose intolerance type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL DIABETES GLUCOSE INTOLERANCE TYPE 2 DIABETES

Contacts and locations

Locations

CH d'Arles - Hôpital Joseph Imbert

Arles, 13637, France
CHU de Montpellier - Hôpital Arnaud de Villeneuve

Montpellier, 34295, France
CHU de Montpellier - Hôpital Lapeyronie

Montpellier, 34295, France
CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.